Deep Brain Stimulation Devices Market for Parkinson’s disease Expected to Reach USD 9.4 Billion Globally in 2019: Transparency Market Research

March 18, 2014

ALBANY, New York, March 18, 2014 /PRNewswire/ –

According to a new market report published by Transparency Market Research “Deep Brain
Stimulation Devices Market for Parkinson’s Disease (North America, Europe, Asia-Pacific
and Latin America)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 – 2019,” the global deep brain stimulation devices market was valued at USD 4.5
billion in 2012 and is expected to grow at a CAGR of 11.0% from 2013 to 2019, to reach an
estimated value of USD 9.4 billion in 2019.

Browse Global Deep Brain Stimulation Devices Market Report with Full TOC at


Rising number of neurological disorders such ischemic stroke, Alzheimer’s disease,
essential tremors, trauma and especially Parkinsonism are primary factors responsible for
the growth of deep brain stimulation devices market. Parkinson’s disease is the second
most common chronic and progressive neurodegenerative disorder characterized by postural
instability, bradykinesia, akinesia and tremors due to loss of dopamine producing neurons
in substantia nigra of mid-brain.

In addition, rise in geriatric population along with augmented demand for minimally
invasive surgical techniques have boosted the overall growth of this market. Moreover,
increase in preference of patients and healthcare professionals to adopt surgical DBS
devices over drug therapy owing to its significantside effects and lack of effectiveness
is further expected to drive the market in coming years.

According to the Parkinson’s DiseaseFoundation (PDF), it has been estimated that
approximately 10 million people worldwide and one million Americans are living with
Parkinson’s disease. Among these, in U.S. approximately 60,000 people are diagnosed with
Parkinson’s disease each year. There are different treatment options available for
Parkinson’s disease that include drug therapy, surgical therapy, physical therapy and stem
cell therapy. However, DBS surgical therapy is mostly preferred in advanced stages of the
disease while in early stages chemotherapy is used.

The global deep brain stimulation devices market is segmented geographically into
North America, Europe, Asia-Pacific and Latin America. Among these, North America accounts
for the largest market share of deep brain stimulation devices market and is valued to be
more than USD 2billion in 2012 owing to rise in number of patients who are adopting
surgical therapy for Parkinson’s disease and rise in geriatric population. In addition,
favorable government reimbursement policies and growing side effects from medication
treatment are further expected toboost the growth of the market in this region. The market
for North America is followed by Europe, Latin America and Asia-Pacific. Contributing
factors for the lowest market share of deep brain stimulation devices in Asia-Pacific
include lack of favorable government insurance policies and high cost for surgical

Browse Deep Brain Stimulation Devices Market Report at


The major players of this market include Medtronic, Inc., St. Jude Medical, Inc. and
Boston Scientific Corporation. Other companies active in this market include Sapiens
Neuro, Aleva Neurotherapeutics SA, ANM Adaptive Neuromodulation GmbH, Synaptix,
Neurosigma, Inc. and Neurospace. The DBS products of these “Other” players are not yet
commercially available in the market since they are still under clinical trials. Companies
are heavily focusing on introducing innovative products that are easy to use for
physicians as well as patients. These companies are also aiming to make them more

Related & Recently Published Reports by Transparency Market Research

        - Antibacterial Drugs Market:


        - Seasonings and Spices Market:


        - Surgical Equipment Market:


        - Polymethyl Methacrylate (PMMA) Market:


        - Prenatal and New-born Genetic Testing Market:


The globaldeep brain stimulation devices market for Parkinson’s disease is segmented
as follows:

Deep Brain Stimulation Devices Market, By Geography

        - North America
        - U.S.
        - Canada
        - Europe
             - Germany
             - U.K.
             - France
             - Italy
             - Spain
             - Poland
             - Netherlands
             - Greece
             - Belgium
             - Portugal
        - Asia-Pacific
             - Australia
             - New Zealand
             - Japan
             - India
             - China
        - Latin America
             - Brazil
             - Mexico
             - Argentina
             - Chile

Browse all Medical Devices Market Research Reports @


About Us

Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze

Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business


Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com

Blog: http://www.tmrblog.com

Blog: http://transparencymarketresearch.areavoices.com

SOURCE http://www.transparencymarketresearch.com/

Source: PR Newswire

comments powered by Disqus